2m 2m 2m 2m 2m 2m 2m
MAZE THERA (MAZE)
NASDAQ
$26.41+$0.84 (+3.29%)
Price as of Jun 23, 2026 5:13 PM EDT- $1.4BMarket Cap
- 138.30%1-Year Change
- BiotechnologyIndustry
MAZE THERA (MAZE)
$26.41+$0.84 (+3.29%)
MAZE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $25.57 | ||
Change | -$0.11 (-0.43%) | ||
Open | $25.69 | ||
High | $26.02 | ||
Low | $25.34 | ||
Previous Close | $25.68 | ||
Volume | 530,342 | ||
30-Day Average Volume | 555,396 | ||
1-Week Change | 5.36% | ||
1-Month Change | -0.81% | ||
1-Year Change | 138.30% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 55.3M | ||
Total Assets | $419.7M | ||
Market Cap | $1.4B | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | $20.0M | ||
Net Income | -$24.2M | ||
Free Cash Flow | -$39.2M | ||
EBIT | -$23.3M | ||
EBITDA | -$22.9M | ||
Net Working Capital | $358.5M | ||
EPS | -$0.45 | ||
Enterprise Value/EBITDA | -55 | ||
Enterprise Value/Revenue | 63 | ||
P/B | 4 | ||
P/E | -57 | ||
PEG | -2 | ||
Price/Free Cash Flow | -36 | ||
Price/Operating Cash Flow | -36 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue